Advertisement
Singapore markets close in 7 hours 40 minutes
  • Straits Times Index

    3,297.14
    +4.21 (+0.13%)
     
  • Nikkei

    38,236.07
    -38.03 (-0.10%)
     
  • Hang Seng

    18,475.92
    0.00 (0.00%)
     
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • Bitcoin USD

    64,418.09
    +1,106.87 (+1.75%)
     
  • CMC Crypto 200

    1,335.82
    +58.84 (+4.61%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • Dow

    38,675.68
    +449.98 (+1.18%)
     
  • Nasdaq

    16,156.33
    +315.33 (+1.99%)
     
  • Gold

    2,314.80
    +6.20 (+0.27%)
     
  • Crude Oil

    78.40
    +0.29 (+0.37%)
     
  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     
  • FTSE Bursa Malaysia

    1,594.35
    +4.76 (+0.30%)
     
  • Jakarta Composite Index

    7,134.72
    -7,117.42 (-49.94%)
     
  • PSE Index

    6,615.55
    -31.00 (-0.47%)
     

Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Autolus Therapeutics plc
Autolus Therapeutics plc

LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its first quarter 2024 financial results and operational highlights before open of US markets on Tuesday, May 14, 2024.

Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

ADVERTISEMENT

Contact:

Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com

Julia Wilson
+44 (0) 7818 430877 
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303 
susan@sanoonan.com